Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
Code | Description | Unit |
---|---|---|
USP-1273808 | Flumazenil | 200 mg |
USP-1273819 | Flumazenil Related Compound A - 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha] [1,4]benzodiazepine-3-carboxylic acid | 20 mg |
USP-1273820 | Flumazenil Related Compound B - Ethyl 8-hydroxy-5,6-dihydro-5-methyl-6-oxo-4H-imidazol-[1,5-alpha] [1,4]benzodiazepine-3-carboxylate | 20 mg |
USP-1273841 | Flumazenil Related Compound C - N,N-Dimethylformamide diethyl acetal | 500 mg |
USP-1274006 | Flumethasone Pivalate | 200 mg |
USP-1274505 | Flunisolide | 200 mg |
USP-1274607 | Flunixin Meglumine | 300 mg |
USP-1275009 | Fluocinolone Acetonide | 100 mg |
USP-1276001 | Fluocinonide | 100 mg |
USP-1277004 | Fluorescein | 200 mg |
USP-1277252 | Fluoride Dentifrice: Sodium Fluoride/Silica | unit |
USP-1277274 | Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder | unit |
USP-1277300 | Fluoride Dentifrice: Sodium Monofluorophosphate - Calcium Carbonate | unit |
USP-1277354 | Fluoride Dentifrice: Sodium Monofluorophosphate/Dicalcium Phosphate | unit |
USP-1277401 | Fluoride Dentifrice: Sodium Monofluorophosphate (1000 ppm)/Silica | unit |
USP-1277423 | Fluoride Dentifrice: Sodium Monofluorophosphate (1500 ppm)/Silica | unit |
USP-1277456 | Fluoride Dentifrice: Stannous Fluoride-Silica | unit |
USP-1278007 | Fluorometholone | 200 mg |
USP-1278109 | Fluorometholone Acetate | 200 mg |
USP-1278302 | Fluoroquinolonic Acid | 150 mg |
USP-1279000 | Fluorouracil | 250 mg |
USP-1279804 | Fluoxetine Hydrochloride (HCl) | 200 mg |
USP-1279815 | Fluoxetine Related Compound A - N-methyl-3-phenyl-3-[(alpha,alpha,alpha-(trifluoro-m-tolyl)oxy]propylamine Hydrochloride (HCl) | 15 mg |
USP-1279837 | Fluoxetine Related Compound C - N-Methyl-N-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl] succinamic acid | 15 mg |
USP-1280009 | Fluoxymesterone CIII (controlled substance in USA) | 200 mg |
USP-1280803 | Fluphenazine Decanoate Dihydrochloride | 300 mg |
USP-1281001 | Fluphenazine Enanthate Dihydrochloride | 125 mg |
USP-1282004 | Fluphenazine Hydrochloride (HCl) | 125 mg |
USP-1283200 | Formic Acid | 3 x 1,2 mL |
USP-1283244 | Forskolin 7Beta-acetoxy-8,13-epoxy-1alpha,6Beta,9alpha-trihydroxy-labd-14-en-11-one | 40 mg |
USP-1283255 | Powdered Forskohlii Extract | 500 mg |
USP-1283302 | Foscarnet Sodium | 50 mg |
USP-1283313 | Foscarnet Related Compound B - Disodium (Ethoxyoxidophosphanyl) formate | 10 mg |
USP-1283324 | Foscarnet Related Compound D - O,O-diethyl ethoxycarbonylphosphonate | 0,27 mL |
USP-1283404 | Fosinopril Sodium | 200 mg |
USP-1283415 | Fosinopril Related Compound A - (4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]-acetyl-L-proline | 25 mg |
USP-1283426 | Fosinopril Related Compound B - ((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline propionate (ester), hemibarium salt, sesquihydrate) | 15 mg |
USP-1283437 | Fosinopril Related Compound C - (4S)-4-cyclohexyl-1-[(RS)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]-acetyl-L-proline propionate (ester),sodium salt | 15 mg |
USP-1283448 | Fosinopril Related Compound D - (4R)-4-cyclohexyl-1-[(R)-[(S]-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt | 15 mg |
USP-1283459 | Fosinopril Related Compound E - (4S)-4-phenyl-1-[(R)-[(S)-1-hydroxy-2-methyl-propoxy](4-phenylbutyl]phospinyl]acetyl-L-proline propionate (ester), sodium salt | 15 mg |
USP-1283460 | Fosinopril Related Compound F - (4S)-4-cyclohexyl-1-[(R)-[(S)-1-hydroxypropoxy](4-phenylbutyl)phospinyl]acetyl-L-proline propionate (ester),sodium salt | 15 mg |
USP-1283470 | Fosinopril Related Compound G - (4-phenylbutyl)phosphinyl acetic acid, disodium salt | 15 mg |
USP-1283481 | Fosinopril Related Compound H - 4-phenylbutyl phosphonic acid | 25 mg |
USP-1284000 | Flurandrenolide | 100 mg |
USP-1285308 | Flurazepam Related Compound C - 5-chloro-2-(2-diethylaminoethyl(amino)-2'-fluorobenzophenone Hydrochloride (HCl) | 50 mg |
USP-1285603 | Flurazepam Related Compound F - 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one) | 50 mg |
USP-1285750 | Flurbiprofen | 200 mg |
USP-1285760 | Flurbiprofen Related Compound A - 2-(4-Biphenylyl)propionic Acid | 100 mg |
USP-1285807 | Flurbiprofen Sodium | 200 mg |
USP-1285840 | Fluticasone Propionate Related Compounds Mixture | 25 mg |
USP-1285851 | Flutamide | 200 mg |
USP-1285862 | o-Flutamide | 50 mg |
USP-1285873 | Fluticasone Propionate | 100 mg |
USP-1285884 | Fluticasone Propionate Resolution Mixture | 25 mg |
USP-1285895 | Fluticasone Propionate System Suitability Mixture Fluticasone Propionate and Fluticasone Propionate Related Compounds B, C and D | 25 mg |
USP-1285909 | Fluvoxamine Maleate | 200 mg |
USP-1285910 | Fluticasone Propionate Nasal Spray Resolution Mixture | 25 mg |
USP-1285931 | Fluvastatin Sodium | 350 mg |
USP-1285942 | Fluvastatin for System Suitability Fluvastatin sodium and fluvastatin sodium anti-isomer ([R*,R*-E](+/-)-7-[3-(4-fluorophenyl)-1-(methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid monosodium salt | 25 mg |
USP-1285964 | Fluvastatin Related Compound B - [R*,S*-E](+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1-dimethylethyl ester | 15 mg |
USP-1285986 | (N-[4-nitro-3-(trifluoromethyl)phenyl]acetamide) | 20 mg |
USP-1285997 | Flutamide Related Compound A | 20 mg |
USP-1286005 | Folic Acid (Vitamin M or Vitamin Bc) | 500 mg |
USP-1286027 | Folic Acid Related Compound A - Calcium Formyltetrahydrofolate | 50 mg |
USP-1286060 | Formononetin | 50 mg |
USP-1286107 | Formoterol Fumarate | 100 mg |
USP-1286118 | Formoterol Fumarate System Suitability Mixture | 20 mg |
USP-1286129 | Formoterol Fumarate Resolution Mixture | 20 mg |
USP-1286209 | Mafenide Related Compound A - 4-Formylbenzenesulfonamide | 50 mg |
USP-1286300 | 10-Formylfolic Acid | 25 mg |
USP-1286322 | Fosfomycin Tromethamine | 800 mg |
USP-1286366 | Fosphenytoin Sodium | 250 mg |
USP-1286504 | Fructose | 125 mg |
USP-1286606 | L-Fucose | 200 mg |
USP-1286650 | Fulvestrant | 150 mg |
USP-1286661 | Fulvestrant System Suitability Mixture | 15 mg |
USP-1286708 | Fumaric Acid | 200 mg |
USP-1286800 | Furazolidone | 200 mg |
USP-1287008 | Furosemide | 200 mg |
USP-1287020 | Furosemide Related Compound A - 2-Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid | 50 mg |
USP-1287030 | Furosemide Related Compound B - 4-Chloro-5-sulfamoylanthranilic Acid | 100 mg |
USP-1287303 | Gabapentin | 250 mg |
USP-1287325 | Gabapentin Related Compound A - 2-Azaspiro[4.5]decan-3-one | 50 mg |
USP-1287347 | Gabapentin Related Compound B - (1-cyanocyclohexyl)acetic acid | 30 mg |
USP-1287358 | Gabapentin Related Compound D - (1-(3-oxo-2-aza-spiro[4,5]dec-2-ylmethyl)-cyclohexyl)acetic acid | 10 mg |
USP-1287369 | Gabapentin Related Compound E - carboxymethyl-cyclohexanecarboxylic Acid | 25 mg |
USP-1287507 | Gadodiamide | 500 mg |
USP-1287518 | Gadodiamide Related Compound A - gadolinium sodium diethylenetriamine pentaacetic acid monomethylamide | 50 mg |
USP-1287529 | Gadodiamide Related Compound B - gadolinium disodium diethylenetriamine pentaacetic Acid | 50 mg |
USP-1287609 | Gadopentetate Monomeglumine | 250 mg |
USP-1287631 | Gadoteridol | 500 mg |
USP-1287642 | Gadoteridol Related Compound A - 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclodedodecane-1,4,7-triaacetic Acid | 50 mg |
USP-1287653 | Gadoteridol Related Compound B - 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, monogadolinium salt | 50 mg |
USP-1287664 | Gadoteridol Related Compound C - 1,4,7,10-Tetraaza-11-oxo-bicylco[8.2.2]tetradecane-4,7-diacetic Acid | 50 mg |
USP-1287675 | Gadoversetamide | 200 mg |
USP-1287686 | Gadoversetamide Related Compound A - Hydrogen[8,11,14-tris(carboxymethyl)-6-oxo-2-oxa-5,8,11,14-tetraazahexadecan-16-oato (4-)]gadolinium | 200 mg |
USP-1287700 | Galactose | 200 mg |
USP-1287711 | Galactitol | 500 mg |
USP-1287722 | Galactosamine Hydrochloride (HCl) | 50 mg |
USP-1287755 | Galantamine HBr | 200 mg |